Paul M. Ridker
0000-0003-1249-4522
Publication & Citation Trends
Publications
0 total
26-A-16637-ACC LDL CHOLESTEROL, NON-HDL CHOLESTEROL, APOLIPOPROTEIN B AND 30-YEAR RISK OF CARDIOVASCULAR DISEASE AMONG HEALTHY WOMEN
Cited by 0
Semantic Scholar
Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.
Cited by 3
Semantic Scholar
26-A-9376-ACC THE TRIGLYCERIDE-TO-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO FOR LONG-TERM CARDIOVASCULAR RISK PREDICTION IN WOMEN
Cited by 0
Semantic Scholar
A plasma glycan score for cardiovascular risk prediction: Secondary analysis of the JUPITER and TNT studies
Cited by 0
Semantic Scholar
hsCRP, High-Risk Plaque, and Pan-Coronary Atherosclerosis: Implications for Patient Care During Acute Myocardial Infarction.
Cited by 3
Semantic Scholar
Statin effects on immunoglobulin-G glycomic architecture and the link to cardiovascular disease
Cited by 0
Semantic Scholar
MEAT INTAKE, METABOLOMICS, AND CARDIOVASCULAR DISEASE RISK IN 27,154 WOMEN
Cited by 0
Semantic Scholar
Research Topics
Lipoproteins and Cardiovascular Health
(410)
Adipokines, Inflammation, and Metabolic Diseases
(273)
Diabetes, Cardiovascular Risks, and Lipoproteins
(174)
Atherosclerosis and Cardiovascular Diseases
(135)
Genetic Associations and Epidemiology
(103)
Affiliations
Oregon National Primate Research Center
AstraZeneca (United Kingdom)
Broad Institute
Boston University
Northwestern University